Biomerica (BMRA)

• Market cap: $5.14M
• 1 day: -3.17%
• 5 days: 11.95%
• 1 month: -25.84%
• 3 months: -6.78%
• 6 months: -30.61%
• Year to date: -75.76%
• 1 year: -75.76%
• 5 years: -89.36%
• 10 years: -90.43%
• Sector: Healthcare
• Industry: In Vitro & In Vivo Diagnostic Substances

About: Biomerica Inc is engaged in the development, manufacturing, and marketing of medical diagnostic products designed for the early detection and monitoring of chronic diseases and medical conditions. The company focuses on products for gastrointestinal diseases, food intolerances, diabetes, and certain esoteric tests. It operates in one segment namely, the design, development, marketing and sales of diagnostic kits. The majority of the company's revenue is earned from the Asia, and also has its presence in Europe, North America, Middle East and South America.

Employees: 64

Fund manager confidence

Based on 2024 Q3 regulatory filings by fund managers ($100M+ AUM)

3.59% less ownership

Funds ownership: 13.25% [Q2] → 9.66% (-3.59%) [Q3]

29% less funds holding

Funds holding: 35 [Q2] → 25 (-10) [Q3]

48% less capital invested

Capital invested by funds: $983K [Q2] → $512K (-$471K) [Q3]

71% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 14

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 12